Fostering surgical innovation: The path forward

Article Type
Changed
Tue, 05/21/2019 - 12:15
Display Headline
Fostering surgical innovation: The path forward
How do we get past the current “chill” on innovation in gynecologic surgery? By talking to innovators themselves, we can discuss and dissect the process, and focus on moving forward.

Click here to download the PDF.

 

Key learning objectives


The faculty for this roundtable aim to:

  1. Explain the process for bringing an innovation to market, including the roles of surgeon inventor, engineer, manufacturer, and industry
  2. Discuss best practices, based on lessons learned, when pursuing an innovative idea for patient care
  3. Articulate ways to improve upon the entire development process for new techniques, devices, etc, being brought to the FDA for possible approval and to market for patient use.
Author and Disclosure Information

Eric R. Sokol, MD
Associate Professor, Obstetrics and Gynecology and Urology
Co-Chief, Urogynecology and Pelvic Reconstructive Surgery
Faculty Fellow, Stanford Biodesign Innovation Program
Stanford University School of Medicine
Stanford, California

Elise M. DeVries, BS
Medical Device Consulting
Biodesign Innovation Fellow
Stanford University Biodesign Innovation Program
Stanford, California

Cheryl B. Iglesia, MD
Director, Section of Female Pelvic Medicine and Reconstructive Surgery
MedStar Washington Hospital Center
Professor, Obstetrics and Gynecology and Urology
Georgetown University School of Medicine
Washington, DC
Member, OBG Management Board of Editors

Peter L. Rosenblatt, MD
Assistant Professor, Obstetrics, Gynecology and Reproductive Biology
Harvard Medical School
Director of Urogynecology
Mount Auburn Hospital
Cambridge, Massachusetts

The authors report no financial relationships relevant to this article.

Publications
Topics
Sections
Author and Disclosure Information

Eric R. Sokol, MD
Associate Professor, Obstetrics and Gynecology and Urology
Co-Chief, Urogynecology and Pelvic Reconstructive Surgery
Faculty Fellow, Stanford Biodesign Innovation Program
Stanford University School of Medicine
Stanford, California

Elise M. DeVries, BS
Medical Device Consulting
Biodesign Innovation Fellow
Stanford University Biodesign Innovation Program
Stanford, California

Cheryl B. Iglesia, MD
Director, Section of Female Pelvic Medicine and Reconstructive Surgery
MedStar Washington Hospital Center
Professor, Obstetrics and Gynecology and Urology
Georgetown University School of Medicine
Washington, DC
Member, OBG Management Board of Editors

Peter L. Rosenblatt, MD
Assistant Professor, Obstetrics, Gynecology and Reproductive Biology
Harvard Medical School
Director of Urogynecology
Mount Auburn Hospital
Cambridge, Massachusetts

The authors report no financial relationships relevant to this article.

Author and Disclosure Information

Eric R. Sokol, MD
Associate Professor, Obstetrics and Gynecology and Urology
Co-Chief, Urogynecology and Pelvic Reconstructive Surgery
Faculty Fellow, Stanford Biodesign Innovation Program
Stanford University School of Medicine
Stanford, California

Elise M. DeVries, BS
Medical Device Consulting
Biodesign Innovation Fellow
Stanford University Biodesign Innovation Program
Stanford, California

Cheryl B. Iglesia, MD
Director, Section of Female Pelvic Medicine and Reconstructive Surgery
MedStar Washington Hospital Center
Professor, Obstetrics and Gynecology and Urology
Georgetown University School of Medicine
Washington, DC
Member, OBG Management Board of Editors

Peter L. Rosenblatt, MD
Assistant Professor, Obstetrics, Gynecology and Reproductive Biology
Harvard Medical School
Director of Urogynecology
Mount Auburn Hospital
Cambridge, Massachusetts

The authors report no financial relationships relevant to this article.

How do we get past the current “chill” on innovation in gynecologic surgery? By talking to innovators themselves, we can discuss and dissect the process, and focus on moving forward.
How do we get past the current “chill” on innovation in gynecologic surgery? By talking to innovators themselves, we can discuss and dissect the process, and focus on moving forward.

Click here to download the PDF.

 

Key learning objectives


The faculty for this roundtable aim to:

  1. Explain the process for bringing an innovation to market, including the roles of surgeon inventor, engineer, manufacturer, and industry
  2. Discuss best practices, based on lessons learned, when pursuing an innovative idea for patient care
  3. Articulate ways to improve upon the entire development process for new techniques, devices, etc, being brought to the FDA for possible approval and to market for patient use.

Click here to download the PDF.

 

Key learning objectives


The faculty for this roundtable aim to:

  1. Explain the process for bringing an innovation to market, including the roles of surgeon inventor, engineer, manufacturer, and industry
  2. Discuss best practices, based on lessons learned, when pursuing an innovative idea for patient care
  3. Articulate ways to improve upon the entire development process for new techniques, devices, etc, being brought to the FDA for possible approval and to market for patient use.
Publications
Publications
Topics
Article Type
Display Headline
Fostering surgical innovation: The path forward
Display Headline
Fostering surgical innovation: The path forward
Sections
Disallow All Ads
Alternative CME
Use ProPublica